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Summary 
The highly complex neocortex is a mammalian specific region of the brain. In 
humans, several areas of the neocortex have been linked to normal cognitive 
functioning. Importantly, abnormalities in the neocortex are associated with serious 
psychiatric disorders, such as schizophrenia and bipolar affective disorder, to which 
cognitive dysfunctions have been linked.  
The specific gene expression in a certain region or organ often reflects the functional 
specialisation of the given area. However, surprisingly few genes have been 
demonstrated to display a regional pattern of expression in adult neocortex. In fact, 
the global gene expression in various functionally and anatomically distinct areas of 
the neocortex seems to be almost identical across regions. In this work we have used 
microarray-based global gene expression profiling, and identified 65 regionally 
enriched genes in the frontomedial-, temporal- and occipital cortices of the adult rat 
neocortex (30, 24 and 11 genes, respectively). A substantial portion of these genes 
seemed to be involved in signal transduction processes. In addition, many of them 
were found to display layer- and cell type specific expression. We proposed that these 
genes could be important to sustain the normal function in a given cortical area. 
Based on the importance of the neocortex in normal cognitive functioning, we used 
these differentially expressed genes, as candidate genes, to mine a large genome-wide 
association study of healthy adults for association to nine psychometric tests. At the 
single gene level, we found that several of the 65 candidate genes displayed 
association to various test measures of cognitive abilities. In addition, we applied 
gene set enrichment analysis of the candidate genes, and found that the genes 
differentially expressed in the temporal cortex, as a set, displayed a significant 
enrichment of association signal to a test measure of non-verbal intelligence. Since 
cognitive dysfunctions are often observed in patients suffering from serious 
psychiatric disorders, we also analysed the candidate genes in large genome-wide 
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association studies of schizophrenia and bipolar affective disorder. However, none of 
the candidate genes, at the gene set level, seemed to be associated to these illnesses.  
In this work we have also partially characterised one of the 65 regionally enriched 
genes, the unannotated gene hypothetical protein LOC689986, which displayed an 
almost exclusive gene expression in samples from the temporal cortex. Here we 
report that this unique gene is highly conserved in, and apparently specific for, the 
vertebrate lineage. The gene displayed a restricted area- and layer specific expression 
in the parieto-temporal cortex, and in addition we found that the LOC689986 protein 
was present in the somatosensory cortex and the Purkinje cells of the cerebellar 
cortex in rodents. The protein was found to localise to neuronal dendrites, and 
identification of potential protein interaction partners suggests a role for this protein 
in transcriptional regulation, and possibly the translational machinery.  
In summary, we have identified and partially characterised, genes that could be 
important to sustain the normal function of selected areas of the neocortex. 
Furthermore, we have analysed such genes for association to cognitive functioning 
and psychiatric disorders. Our results suggest that genes differentially expressed in 
the temporal cortex could be involved in mechanisms of non-verbal intelligence.   
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1. Introduction 
The brain is by far the most complex organ in the human body, and stands 
responsible for our thoughts, memories, feelings, actions and the perception of our 
surroundings. Based on anatomy and functional aspects, the brain is divided into 
highly specialised structures. One of these structures, the cerebral cortex, constitutes 
the largest part of the brain, and in humans the cerebral cortex is estimated to account 
for as much as 77% of the total volume of the brain [reviewed in 1]. It harbours 
specialised functional properties, ranging from processing and interpretation of 
sensory information to the conscious control of motor function. One of the 
remarkable attributes of the cortex is higher intellectual functioning, which is 
outstanding in humans, and sets us apart from non-human primates and other 
mammalian species.  
Despite the prominent role of the cortex in cognitive functions, the underlying 
mechanisms explaining how the numerous cortical neurons are connected and 
function to make up the highly complex structure, remain elusive. We do, however, 
have substantial knowledge about the basic organisation, development, evolution and 
functional organisation of the cerebral cortex.  
In the following I will present relevant topics on the mammalian cortex, and how 
cognitive abilities and psychiatric disorders relate to this extraordinary structure. 
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1.1 The mammalian neocortex 
1.1.1 Basic structural organisation of the mammalian neocortex 
The cerebral cortex is located at the anterior part of the mammalian brain (superior 
orientation in humans), surrounding the cerebrum (the main brain) (Figure 1). Based 
on cellular lamination, the cerebral cortex can be divided into the neocortex (also 
called isocortex or homogeneous cortex) and the allocortex (also known as the 
heterogenic cortex). The highly complex neocortex constitutes the phylogenetically 
most recent addition to the brain, and has been estimated to contain approximately 20 
billion neurons in humans [2]. Anatomically, the neocortex is divided into four main 
areas, namely the frontal-, parietal-, temporal- and occipital lobes (Figure 1). Each of 
the four lobes is associated with various functional domains, such as higher mental 
functioning in the frontal lobe and processing of auditory, visual and sensory 
information in the temporal-, occipital- and parietal lobe, respectively (Figure 1). 
 
 
 
Figure 1: Lobes of the brain. The figure shows a lateral view of the human brain, illustrating the 
folded neocortex surrounding the left hemisphere of the brain. The four different lobes are illustrated. 
Blue: frontal lobe, yellow: parietal lobe, green: temporal lobe and pink: occipital lobe. Specific 
functions associated with the different regions of the neocortex, such as vision, hearing and speech, 
are indicated. The image is taken from http://headwayballymena.org.uk/page3.html. 
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In the horizontal dimension, the mature neocortex is organised as a sheet composed 
of six cellular layers (Figure 2), each of which is comprised of heterogeneous 
populations of morphological and connectional distinct neurons. In general, these 
cortical neurons can be divided into two broad classes, namely projection neurons 
(also known as pyramidal or excitatory neurons) and interneurons (also called 
inhibitory or local circuit neurons). The projection neurons are glutamatergic (i.e. 
they use glutamate as a neurotransmitter) and make intra-cortical, sub-cortical and 
sub-cerebral connections. In contrast, the interneurons normally use Ȗ-aminobutyric 
acid (GABA) as a neurotransmitter, and make local connections [reviewed in 3]. Of 
the six layers of the neocortex, layer I (molecular layer) is the outermost layer, mainly 
made up of dendritic clusters originating from distal pyramidal neurons. A scattered 
pattern of interneurons is also observed in this layer, as well as many axon 
terminations [reviewed in 4]. Layer II (external granular layer) comprises mainly 
stellate neurons, in addition to a scattered pattern of small pyramidal neurons. Layer 
III (external pyramidal layer) of the neocortex is primarily composed of small 
projection neurons, while layer IV (internal granular layer) predominantly contains 
different types of stellate and small pyramidal neurons. Layer V (internal pyramidal 
layer) consists of large pyramidal neurons, while a great number of small spindle-like 
pyramidal and multiform neurons, in addition to a few large pyramidal neurons, make 
up the innermost layer VI (polymorphic/multiform layer) [5].  
In the radial dimension, the neocortex is intersected by vertical columns consisting of 
synaptically linked neurons from layer II-VI (Figure 2) [reviewed in 6]. These 
vertically organised neurons (minicolumns) are the basic unit of the neocortex. Short 
range horizontal connections couple several minicolumns together, and thereby make 
up a cortical column. The cortical columns link both input and output projections, 
making them highly complex processing and distributing units of the neocortex 
[reviewed in 6]. The excitatory pyramidal neurons are arranged in the same basic 
tangential and laminar organisation in all mammals [reviewed in 4]. Afferent 
thalamic and cortical input signals arrive in cortical layer IV, where the axons of 
excitatory neurons subsequently project to the superficial layers (II and III). 
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Pyramidal neurons within the superficial layers project to other cortical areas, and to 
the deeper layer V which in turn is connected to layer VI. Excitatory neurons in layer 
VI project to layer IV, closing the neuronal circuit [for review see 4,7]. 
 
 
Figure 2: Basic structural organisation of the mammalian neocortex. The neocortex is organised 
into a six-layered structure in its horizontal dimension (left). The roman numerals indicate the 
different neocortical layers, from the outermost (layer I) to the innermost layer (layer VI). The 
neocortex is intersected radially by vertical columns (right). The image is modified from http://www. 
sbirc.ed.ac.uk/cyril/cp_neurophysio2.html. 
 
1.1.2 Neocortical neurogenesis  
All of the numerous projection neurons within the neocortex are generated in 
transient proliferative zones, situated immediately adjacent to the surface of the 
lateral ventricles in the dorsal forebrain. The first proliferative zone to emerge during 
the embryonic development is the ventricular zone (VZ), followed by the sub-
ventricular zone (SVZ) and the outer sub-ventricular zone (OSVZ) as the 
neurogenesis proceeds [reviewed in 3,8]. Several cortical progenitor cells have been 
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identified, that give rise to all the various neuronal cell types. At the beginning of 
neurogenesis, neuroepithelial cells mainly undergo symmetric cell divisions, in order 
to generate a large pool of progenitors. These cells transform into the radial glia (RG) 
cells, which are situated in the VZ (Figure 3). The radial glia cells constitute the 
majority of progenitor cells in rodents [9,10], and to some extent in primates 
[reviewed in 11]. The RG cells project to the cortical surface, and undergo both 
symmetric and asymmetric division, giving rise to numerous neuronal cell types [12-
14]. An important feature of the radial glia cells is that they enable postmitotic 
neurons to migrate to their appropriate layers (according to the “radial unit 
hypothesis” [15]), where they bypass the previous layers in a fashion known as the 
“inside-out gradient of neurogenesis” [reviewed in 16].  
 
 
Figure 3: Progenitor cells in the developing neocortex. Radial glia (RG) progenitor cells are 
situated in the ventricular zone (VZ), making projections towards the cortical surface. RG cells 
undergo both asymmetric and symmetric division, and provide a scaffold for neuronal migration to 
the appropriate neocortical layer. Intermediate progenitor (IP) cells reside in the sub-ventricular zone 
(SVZ) and undergo symmetric division. In primates, outer-radial glial (ORG) progenitor cells are 
situated in the outer SVZ (OSVZ). ORG cells make projections to the cortical surface and are able to 
go through both asymmetric and symmetric cell divisions. Similar to the RG cells, the ORG cells 
provide a scaffold for migrating neurons generated in the OSVZ. The figure is taken with permission 
from [17]. 
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In addition to providing a scaffold for migrating neurons, the radial glia cells give rise 
to the intermediate progenitor (IP) cells (Figure 3) [18-21]. These cells migrate to the 
upper part of the ventricular zone to create a new proliferating zone, namely the sub-
ventricular zone. In contrast to RG cells, intermediate progenitor cells are only able to 
undergo symmetric cell division [18]. However, the IP cells constitute the majority of 
neuron producing cells compared to the RG cells in rodents [22]. An expansion of the 
outer region of the sub-ventricular zone (the OSVZ) has been observed in the primate 
developing neocortex (Figure 3) [reviewed in 8,17]. This region is populated by RG-
like cells (called outer-radial glia (ORG) cells) in addition to IP cells. The ORG cells 
originate from the radial glia cells in the ventricular zone, and constitute a second 
pool of progenitor cells which are able to go through both symmetric and asymmetric 
cell divisions, giving rise to neurons and new progenitor cells [23,24]. In contrast to 
radial glia cells, the ORG cells lack contact with the ventricular surface. However, 
they project to the cortical plate, functioning as scaffolds for migrating neurons 
[reviewed in 8]. 
1.1.3 Arealisation and functional organisation of the neocortex 
During embryonic development the mammalian neocortex is divided into specific 
neocortical areas through a process termed arealisation. This developmental process 
is crucial for the establishment of the unique functional properties, interactions with 
other areas of the brain as well as the appropriate size of a given area [reviewed in 
25]. Control of the arealisation is thought to involve an interplay between intrinsic 
genetic regulation of the neocortex and external influence from thalamic projection 
neurons [reviewed in 26]. Early in neocortical development, morphogens are secreted 
from telencephalic patterning centres, which in turn initiate anterior–medial and 
posterior–lateral gradients of transcription factors in progenitor cells in the cortical 
ventricular zone (i.e. Emx2, Pax6, COUP-TFI, Sp8) [27-38]. The graded expression 
of various transcription factors is crucial for the area identity of the cortical 
progenitor cells. This area identity is subsequently conferred to the neuronal progeny 
which makes up the cortical plate [reviewed in 25]. Moreover, expression of specific 
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guidance molecules ensures the proper thalamocortical axon innervations of the 
developing neocortex. It has long been debated whether or not the thalamocortical 
input projections induces the structural differences in the neocortex (“protocortex” 
hypothesis [39]). However, it is now generally accepted that intrinsic regulation (i.e. 
by differential gene expression in progenitor cells in the VZ) is the key factor in 
defining specific areas (“protomap” hypothesis [15]), and that these areas attract the 
appropriate thalamocortical axons, rather than being specified by them [reviewed in 
40].  
In general, the mature neocortex can be divided into four main functional areas in all 
mammalian species. These areas include the primary visual-, the somatosensory-, the 
auditory- and the motor area, located within the occipital-, parietal-, temporal- and 
frontal lobes, respectively (Figure 1). Each of these functionally distinct regions 
receive specific thalamic input projections [reviewed in 25]. However, several other 
distinct functional domains can be recognised, based on differences in 
cytoarchitecture, chemoarchitecture, input and output projections, and patterns of 
gene expression. At first glance, the cytoarchitecture of the mature neocortex may 
appear uniform. Nonetheless, there is substantial variability in neocortical areas based 
on lamination, connectivity and neurochemistry [reviewed in 41]. As an example, 
more than 50 distinct cytoarchitectonic regions (also called Brodmann Areas) have 
been distinguished in the human brain [reviewed in 40], each harbouring highly 
specific functions. Damage to certain regions, such as the Broca’s or Wernicke’s 
areas, results in difficulties, or inability to process language and generation of speech 
[reviewed in 41], clearly illustrating that distinct anatomical regions are responsible 
for highly specialised functions. 
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1.1.4 Differential gene expression in the mammalian brain  
The global gene expression (transcriptome) in various parts (e.g., neocortex, 
cerebellum, hippocampus, striatum) of the mammalian central nervous system (CNS), 
differs substantially and clearly distinguishes distinct regions from each other (Figure 
4) [42-46]. Importantly, the regionally enriched gene expression in different brain 
areas has been demonstrated to reflect the functional activity of the given region 
[42,45]. In contrast, the transcriptome in sub-areas within the adult neocortex has 
been shown to be surprisingly similar [42,44,45] (Figure 4), despite the specialised 
functions attributed to distinct cortical regions. In fact, the gene expression in 
different neocortical areas of the adult human brain was demonstrated to be more 
similar within an individual, than between corresponding regions in another 
individual [44]. It appears that differential gene expression across cortical areas is 
relatively rare [reviewed in 47]. However, several studies have reported on a limited 
number of genes displaying highly area specific expression within functionally 
distinct regions of both primate (e.g. primary sensory, association and motor cortices) 
[44,48-52] and rodent neocortex [46,52-54]. 
It has been suggested that the region-specific gene expression is a result of 
differential distribution of a certain cell type across cortical areas, which specifically 
expresses a certain gene. This has been demonstrated for a few genes selectively 
expressed by a certain cell type within a specific cortical layer (e.g. Nuclear receptor 
related 1 protein) [reviewed in 55]. In contrast, it has also been proposed that 
regionally enriched genes are expressed in a wide range of neuronal cell types, and 
undergo dynamic regulation during neocortical maturation [reviewed in 47]. The 
biological significance of such area-specific gene expression in the mature neocortex 
is slowly emerging. As an example, the products of genes selectively expressed in the 
primate visual cortex areas (e.g. occipital 1- related family genes), have been 
suggested to be involved in conferring stability on neuronal circuits. This is important 
since newly acquired information (in this case by visual input) would be lost under 
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conditions where there is too much plasticity. In contrast, the neuronal circuits would 
not be formed if the stability was too high [reviewed in 56].  
 
 
Figure 4: A hierarchical clustering of various brain and non-CNS tissues from the adult rat. 
The transcriptomes of various brain and non-CNS tissue samples from the adult rat differ 
substantially from each other. CNS and non-CNS samples are clearly separated (red and blue colour, 
respectively), as are the different CNS regions (i.e. cortex, hippocampus, striatum and cerebellum). 
The samples from the three different cortical areas (i.e. FCx, TCx and OCx) do not, however, cluster 
according to region. Individual rats are indicated by numbers (i.e. 4, 6 and 8), L or R: samples from 
the left or right hemisphere, respectively, OCx: occipital cortex, TCx: temporal cortex, FCx: 
frontomedial cortex. The figure is taken with permission from [42]. 
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1.1.5 Evolution of the neocortex 
In general, all mammalian species share some common functional neocortical 
regions, but there is substantial variability in the size of the neocortical surface area, 
functional domains and organisation. An obvious example of this is the large 
difference in size of the primate and rodent neocortex (Figure 5). While the rodent 
neocortex has a smooth surface (lissencephalic), the human and non-human primate 
neocortex is organised into a folded structure (gyrencephalic). Gyrencephalic brains 
are characterised by folds (gyri) separated by depressions (sulci) (Figure 5). 
Generally, the surface area in gyrencephalic mammals is disproportionally increased 
relative to the ventricular surface, as compared to lissencephalic mammals [reviewed 
in 40]. An increase in the number of progenitor cells by symmetric cell division, prior 
to neurogenesis, has most probably led to this enlargement during evolution. The 
increased number of progenitor cells in turn led to an increase in the pool of radial 
glia cells in the ventricular zone, and thereby, ultimately a larger amount of cortical 
columns [reviewed in 40,57]. In addition, an increase in the number of symmetric 
intermediate progenitor cell divisions in the sub-ventricular zone, has also been 
assigned to play a role in the surface area expansion [reviewed in 8]. Moreover, the 
increase in neocortical surface area in gyrencephalic brains, and particularly in the 
human neocortex, is related to an expansion of the pool of outer-radial glia founder 
cells in the outer sub-ventricular zone [23,24,58]. 
The human neocortex comprises several unique functional domains, that are not 
present in phylogenetically “lower” mammalian species (e.g. rodents). These areas 
are thought to be a result of the neocortical surface area expansion during evolution. 
Among others, these include Broca’s and Wernicke’s area, which are involved in 
production and processing of language. Most importantly, human brains are 
characterised by having a large expansion of the prefrontal cortex (Figure 5). The 
specific functions attributed to the prefrontal cortex in humans are associated with 
unique mental abilities, which sets humans apart from non-human primates and other 
mammalian species [reviewed in 40,59].  
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Figure 5: Comparison of the mouse, macaque and human brain. A lateral view of the brain 
illustrates the difference in size of the brain in mouse, macaque and human (the brains are drawn to 
approximately the same scale). The mouse brain has a smooth surface, while the primate brains have 
distinct sulci and gyri. The prefrontal cortex is indicated in blue in the human and macaque brains. 
The image is modified from [40]. 
 
1.2 Cognition 
1.2.1 Cognitive abilities 
The terms cognitive abilities, intelligence, mental ability and IQ (intelligence 
quotient) are often used interchangeably in order to describe a wide range of mental 
processes in humans. These processes include reasoning, working memory, attention, 
executive functioning and speed of processing. Cognitive abilities are strongly 
associated with important life outcomes such as education, professional occupation, 
income and length of life [60, reviewed in 61]. In general, intelligence varies in the 
healthy population, following an approximately normal distribution. A large battery 
of psychometric tests is available to measure cognitive abilities, resulting in an 
estimate of how well an individual performs in solving specific tasks. Such test 
estimates are not at all independent measures, since people who perform well on one 
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specific test also tend to do well on the other psychometric tests. This phenomenon 
can be explained by the “general factor of intelligence” (g), which has been estimated 
to account for 40% (or more) of the observed total variance in cognitive abilities 
[reviewed in 59].  
1.2.2 Cognition and the neocortex 
Interestingly, there is a moderate correlation between intelligence and total brain 
volume in healthy individuals [62]. In addition, a modest positive correlation between 
estimates of general intelligence and volumes of the frontal-, parietal- and temporal 
cortices, as well as the hippocampus, has been reported [62-65]. However, how these 
areas interact, and how they relate to measures of intelligence, remained elusive. 
Recently, based on several magnetic resonance imaging studies, Jung and Haier 
proposed that a network consisting of areas in the dorsolateral prefrontal cortex, 
parietal lobe, anterior cingulate cortex, and areas in the temporal- and occipital lobes 
are linked to differences in cognitive abilities (the parieto-frontal integration theory 
(P-FIT)) (Figure 6) [66]. According to this theory, several areas of the brain are 
thought to influence differences in cognitive abilities between individuals. Regions 
within the occipital lobe (Brodmann Area (BA) 18 and 19) and the temporal lobe 
(BA 37) are involved in recognising visual input, and these signals are further 
processed in areas of the parietal lobe (BA 7, 39 and 40). According to the parieto-
frontal integration theory, the parietal regions interact with areas within the frontal 
lobe (BA 6, 9, 10 , 32, 45 ,46 and 47) in order to generate a working memory 
network and to select the appropriate task response [reviewed in 59].  
The thickness of various cortical regions has also been linked to intelligence 
differences between healthy individuals [67-70]. The analysis of cortical thickness, as 
compared to volumetric estimates, may give a more accurate measure of 
cytoarchitectonic characteristics associated with cognition. The thickness of the 
frontal-, parietal- and occipital cortices, in addition to multimodal association areas, 
has been positively correlated with intelligence [70,71]. Interestingly, a longitudinal 
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study of cortical development in children and adolescents revealed that the 
relationship between intelligence and cortical thickness changes with age, and that 
the pattern of cortical growth during development, primarily in the frontal cortex, is 
related to levels of intelligence [71].  
Brain lesion studies have also provided highly specific relationships between 
neocortical areas and deficits in cognitive abilities. As an example, damage in the left 
frontal and parietal cortices causes difficulties in performance related to working 
memory, while lesions in left inferior frontal cortex cause a decrease in verbal 
comprehension [72].  
 
 
 
 
Figure 6: Areas of the brain involved in cognitive abilities. The Parieto-frontal integration theory 
describes a network of brain regions thought to be involved in cognitive abilities [66]. Brodmann 
Areas (BA) are indicated in each region. BAs coloured green or pink indicate predominantly left or 
right hemispheric correlation with intelligence, respectively. The figure is taken from [59]. 
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1.2.3 The heritablity and genetics of human intelligence  
Twin- and adoption studies have demonstrated a high heritability for cognitive 
abilities, with estimates of genetic influence ranging from 30-80%. Interestingly, such 
estimates have been shown to increase with age [for review see 59,73]. Despite the 
high heritability, the underlying genetic architecture leading to the observed 
differences in cognitive functioning between healthy individuals are not well 
understood. It is generally accepted that intelligence is influenced by variants in a 
large number of genes. Such variants have traditionally been examined by linkage- 
and association- studies, and more recently by genome-wide association studies 
(GWAS). In fact, a recent multi centre GWAS found that thousands of common 
genetic variants account for ~40-50% of the variation in cognitive abilities [74]. 
In GWASs, between several hundred thousand and more than a million genomic 
variants (single nucleotide polymorphisms (SNP)), covering the entire genome, are 
analysed in thousands of individuals [75]. The aim of genome-wide association 
studies is to identify SNP variants occurring at a different frequency in cases than in 
matched controls, and thereby identifying SNPs that are likely to explain differences 
in for example cognition, or variants that underlie the predisposition for developing 
disease.  
Despite an extensive search for the underlying genetic factors important for normal 
cognitive abilities, no single genes or genetic regions have so far been identified to be 
conclusively responsible for the normal variation in cognitive abilities in the healthy 
population [reviewed in 59,73]. This corresponds well with a highly polygenic 
underlying mechanism [74]. However, a limited number of genes has been implicated 
in cognitive abilities. These include reliable association between variants in the 
Apolipoprotein E gene and cognitive abilities and dementia in old age [76,77]. 
Furthermore, Catechol-O-methyltransferase and Brain-derived neurotrophic factor 
are two other examples of genes that have been linked to variation/differences in 
intelligence [78,79,reviewed in 80].  
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1.3 Schizophrenia and bipolar affective disorder 
Patients suffering from serious psychiatric disorders, such as schizophrenia (SCZ) 
and bipolar affective disorder (BP), are often characterised by cognitive dysfunctions. 
Approximately 1% of the general population will be affected by these mental 
illnesses during their lifetime [reviewed in 81], which seriously influence the 
behaviour and function of the patients. The disorders affect each individual’s life-
outcome to a great extent, in addition to imposing large challenges for the society in 
general.  
1.3.1 Clinical symptoms in schizophrenia and bipolar affective disorder 
Patients suffering from schizophrenia are characterised by having a mixture of 
positive and negative symptoms, together with cognitive dysfunctions (e.g., memory, 
processing speed, verbal fluency, attention) and/or mood symptoms [as reviewed in 
82]. The positive symptoms observed in SCZ patients include hallucinations, 
delusions and other reality distortions, while the negative symptoms range from 
blunted or inappropriate affect, loss of motivation, to social and emotional 
withdrawal [reviewed in 82].  
Bipolar affective disorder (also called manic-depressive illness) is characterised by 
episodes of abnormal elevated or irritable mood (manic episode), which results in an 
impairment of social and/or occupational functioning, or psychosis. In addition, most 
patients suffering from BP also experience episodes of severe lowering of mood and 
activity level (depression) [reviewed in 83].  
The onset of both SCZ and BP generally occurs during adolescence or early 
adulthood, and the diagnosis is based on the presence and duration of several of the 
aforementioned symptoms, as described in the 4th Edition of The Diagnostic and 
Statistical Manual of Mental Disorders (DMS-IV-TR) [84] or the International 
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Statistical Classification of Disease and Related Health Problems, 10th Revision 
(ICD-10) [85]. 
1.3.2 Morphological brain abnormalities in schizophrenia and bipolar 
affective disorder 
Several morphological brain changes have been linked to SCZ and BP. In patients 
suffering from SCZ, such changes include reduction of grey matter and cortical 
thinning in areas of the neocortex, namely frontal-, temporal-, cingulate-, occipital-, 
parietal- and insular cortex, as compared to healthy matched controls (Figure 7) 
[86,87]. In BP, there are rather conflicting reports regarding abnormalities in grey 
matter and cortical thickness. Some studies have reported regional reduction of grey 
matter in certain areas (e.g. frontal and temporal regions), decrease in global cortical 
grey matter or thinning of prefrontal cortical areas, while others have shown regional 
increase, or no grey matter abnormalities in BP relative to control subjects [as 
reviewed in 88]. However, based on recent meta-analyses in BP, significant grey 
matter reduction seems to be present in the anterior cingulate and insular cortex 
[86,89]. In addition, a recent analysis of patients suffering from BP, revealed 
substantial neocortical thinning in frontal-, temporal- and temporo-parietal regions 
(Figure 7) [87]. Although morphological changes in the neocortex are apparently 
more extensive in SCZ patients compared to BP, a substantial overlap of areas 
displaying cortical abnormalities in both patient groups has been observed (e.g. 
frontal and temporal lobes, anterior cingulate and bilateral insular cortex) [86,87].  
In addition to the morphological changes in areas of the neocortex, measures of 
global brain volume have revealed a small, but statistically significant reduction of 
the total brain volume in patients with schizophrenia [90]. In contrast, there are 
conflicting reports regarding the total brain volume in BP. No apparent reduction of 
the cerebral volume in patients with bipolar affective disorder has been reported 
[91,92], while others have shown a significant reduction of whole brain and 
prefrontal lobe volumes [93]. Moreover, patients suffering from schizophrenia or 
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bipolar affective disorder may display a substantial, and overlapping pattern of 
volume reduction in sub-cortical areas (e.g. hippocampus, thalamus, nucleus 
accumbens and brainstem) [86,87], and an enlargement of ventricular volume 
[87,92,93].  
 
 
 
Figure 7: Abnormalities in cortical thickness in psychiatric disorders. The image shows 
difference in cortical thickness between individuals suffering from schizophrenia (A) or bipolar 
affective disorder (B), compared to healthy controls. The orientation of the brains is indicated. Red 
and yellow indicate areas of cortical thinning. The image is taken from [87].  
 
 28 
A comparison between individuals with schizophrenia and bipolar affective disorder 
demonstrated that the ventricular enlargement was substantially greater in 
schizophrenia [93]. The overlap in neocortical and sub-cortical structures affected in 
both schizophrenia and bipolar affective disorder has been suggested to reflect a 
common underlying pathophysiology in the two illnesses [86,87]. Interestingly, the 
anterior and insular cortices are connected to the paralimbic structures, which are 
involved in functional systems linked to emotional regulation [86]. Overall, the 
morphological changes observed in schizophrenia are apparently more extensive, 
compared to bipolar affective disorder. 
1.3.3 The genetics of schizophrenia and bipolar affective disorder 
Schizophrenia and bipolar affective disorder are familial and highly heritable 
psychiatric disorders. Through family-, twin- and adoption studies, the heritability 
has been estimated to be as high as 0.7 (i.e. genetic factors explain up to 70% of the 
variance in risk of developing disease) [94-98]. The remaining risk is assigned to 
environmental factors (Figure 8) [99]. Family studies have suggested a shared genetic 
overlap in risk factors between bipolar affective disorder and schizophrenia (Figure 
8). The disorders seem to co-aggregate in families, and an increased risk of 
developing either illness has been observed in individuals with affected first degree 
relatives [98,100].  
Both schizophrenia and bipolar affective disorder are complex genetic disorders, 
where numerous common genetic variants of very small effect are thought to cause 
an increase in disease susceptibility [101]. Over the last decades, great efforts have 
been made to identify genetic factors causing predisposition to illness, mainly 
through linkage-, association- and, more recently, through genome-wide association 
studies. Still, the underlying genetic architecture of schizophrenia and bipolar 
affective disorder remains poorly understood, and so far only a limited number of 
common genetic variants has been implicated in disease susceptibility. 
 
 29
 
 
Figure 8: Variance explained by genetic and environmental effects for schizophrenia and 
bipolar affective disorder. Red colour indicates the variance accounted for by shared genetic effects 
(% of variance illustrated on the x-axis). Light red illustrates the unique genetic effects attributed to 
the two disorders. The dark blue and light blue colours indicate shared and non-shared environmental 
effects, respectively. The image is taken from [98].  
 
These include variants in the major histocompatibility complex (MHC) region 
located on chromosome 6p, which was reported from three independent genome-wide 
association studies to display significant association to schizophrenia [101-103]. The 
most extensive analysis so far combined data from 17 separate schizophrenia GWASs 
in a recent mega-analysis conducted by the Psychiatric Genomics Consortium [104]. 
A similar mega-analysis was performed in bipolar affective disorder [105]. By 
analysing these large samples, 7 and 4 common variants were identified in SCZ and 
BP, respectively, reaching genome-wide significance for association (i.e. P value < 5 
x 10-8) [104,105]. For schizophrenia, five of the seven identified loci had not 
previously been linked to disease susceptibility, while the remaining 2 loci had 
already been associated to disease. The results implicated variants linked to 
microRNA 137 (MIR137) and to the CUB and Sushi multiple domains 1 (CSMD1) 
gene in increased disease susceptibility [104]. For bipolar affective disorder, 
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association was reported for variants in ankyrin 3 (ANK3), synaptic nuclear envelope 
protein 1 (SYNE1), odd Oz/ten-m homolog 4 (ODZ4) and a region on chromosome 12 
[105]. A combined analysis including both schizophrenia and bipolar affective 
disorder patients in a large meta-analysis, further strengthened the finding of genetic 
overlap between the two disorders (i.e. for the genes CACNA1C, ANK3, and the 
ITIH3-ITIH4 region) [104,105].  
In addition to common variants of small effect, some rare variants of relatively large 
effect have been linked to increased disease vulnerability. Such rare variants include 
copy number variations (CNV), in which large regions of the genome (ranging from 
ten thousand to five million basepairs) have either been inserted, duplicated or 
deleted. Patients suffering from schizophrenia have a greater genome-wide burden of 
such structural variants, compared to healthy matched controls, and also to 
individuals affected by BP [106-108]. Such CNVs, associated to disease 
susceptibility, have been identified on chromosomes 1q21.1, 15q13.3, 15q11.2, 
16p11.2 and 22q11.2 [106,109,110]. Another example of a structural variance linked 
to SCZ, is the balanced translocation of the gene Disrupted in schizophrenia 1 
(DISC1) [111]. These structural variants point at the likelihood of schizophrenia 
resulting from a combination of common and rare variants, of small and large effect, 
respectively [107,112,113]. 
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2. Aims of the study 
The overall aim of this study was to identify and characterise differentially expressed 
genes in the rat neocortex, and subsequently explore their possible role as genetic risk 
factors in normal intellectual function and serious psychiatric disorders.  
 
Specific aims: 
 
1. Identify and characterise differentially expressed genes in three neocortical 
regions in the adult rat brain. 
 
2. Search for association between selected regionally enriched cortical genes and 
cognitive abilities and risk for serious psychiatric disorders. 
 
3. Characterise a hitherto unannotated gene that displays an almost exclusive 
expression in the parieto-temporal cortex of the adult rat brain.  
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4. Summary of results 
Paper I 
The mammalian neocortex is divided into anatomically and functionally distinct 
areas. However, the global gene expression in different regions of the neocortex is 
strikingly similar. By microarray-based global gene expression profiling of samples 
from the adult rat brain (i.e. frontomedial-, temporal- and occipital cortex (FMCx, 
TCx and OCx, respectively), striatum, hippocampus and cerebellum), as well as three 
non-CNS samples (i.e. kidney, liver and spleen), we were able to identify distinct sets 
of genes that displayed marked regional enrichment in the three different cortical 
areas (30, 24 and 11 genes enriched in the FMCx, TCx or OCx, respectively). A 
majority of these genes was over-represented in certain biological processes, such as 
signal transduction and developmental processes. Moreover, several of the genes 
were over-represented in molecular functional categories linking them to receptor-, 
signalling molecule- and ion channel function. Finally, a majority of the differentially 
expressed genes displayed enriched expression in neurons, and a laminar pattern of 
expression was observed for a substantial portion of the genes. Based on the 
assumption that regionally enriched genes might reflect functional specialisation of a 
given tissue or organ, we hypothesised that these genes could be important in order to 
sustain the normal function of their respective neocortical areas. 
Paper II  
People differ in cognitive performance, but despite its estimated high heritability, the 
underlying genetic architecture leading to such differences remains poorly 
understood. Different areas of the neocortex have been shown to play important roles 
in normal cognitive functioning and impairments. Moreover, it has been suggested 
 34 
that genes preferentially or specifically expressed in one region or organ might reflect 
functional specialisation. We previously identified a novel set of genes, displaying 
differential expression in three cortical regions from the adult rat brain (FMCx, TCx 
and OCx) (Paper I). By employing a gene-based approach to the analysis, we used 
these candidate genes to mine a genome-wide association study of the Norwegian 
Cognitive NeuroGenetics sample for association to nine psychometric tests. We also 
explored available GWAS data for the serious psychiatric disorders schizophrenia 
and bipolar affective disorder, to which cognitive impairment is linked. At the single 
gene level, we found that the TCx enriched gene RAR-related orphan receptor B 
(RORB) showed the overall strongest association in the analysis, to a test of verbal 
intelligence (P= 7.7E-04). We next applied a gene set enrichment analysis (GSEA) 
approach to search for enrichment of association signal in the Norwegian Cognitive 
NeuroGenetics GWAS and in three GWASs of bipolar affective disorder and of 
schizophrenia. The set of genes differentially expressed in the TCx showed a 
significant enrichment of association signal to a test measure of non-verbal 
intelligence. In contrast, no reliable enrichment of association signal was observed for 
the two psychiatric disorders. The gene-based approach suggested a role for RORB in 
verbal intelligence differences, while the genes showing an enriched expression in the 
TCx could be important to intellectual functions as measured by a test of non-verbal 
intelligence in the healthy population.  
Paper III 
The mammalian neocortex is a highly complex structure which is involved in a wide 
range of tasks, such as processing and interpretation of sensory information and 
control of motor functions. We previously analysed the global gene expression in 
three different cortical regions from the adult rat brain (FMCx, TCx and OCx), and 
identified distinct sets of genes showing regional enrichment (Paper I). One of the 
genes, the hitherto unannotated hypothetical protein LOC689986 (LOC689986) gene, 
displayed an almost exclusive expression in samples from the TCx, and only weak, or 
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no expression in other CNS and non-CNS samples, respectively. Highly or 
specifically expressed genes within a certain region or organ have been suggested to 
reflect the functional specialisation of the given region. We therefore aimed at 
characterising this unannotated gene in detail, in order to gain insight into potential 
functional roles. Blast searches and phylogenetic analysis revealed that the gene was 
conserved in, and apparently specific for, the vertebrate lineage. A detailed RT-PCR- 
and in situ RNA hybridisation based analysis of the LOC689986 gene expression 
pattern in rat, revealed a highly restricted gene expression in areas of the parieto-
temporal cortex, and furthermore, a specific expression in layer 4 of the 
somatosensory cortex (SCx). By analysing the human orthologous gene 
(Chromosome 1 open reading frame 146 (C1orf146)) expression in 8 different human 
brain tissues, we found the highest gene expression level in samples from the frontal 
pole, in addition to expression in samples from the medulla, hippocampus and 
cerebellum. Surprisingly, we detected an exclusive C1orf146 gene expression in 
samples from testis, when microarray data from 32 different human tissues were 
explored. By immunoblot analysis of samples from the adult rat, we found that 
LOC689986 was translated in vivo. The protein seemed to be expressed in samples 
from the temporal and cingulate cortices, in addition to the hippocampus and 
cerebellum. Furthermore, we established that the encoded mouse orthologous protein 
(1700028K03Rik) was present in the SCx, with a rather abrupt border towards the 
neighbouring motor cortex. In addition, we detected protein expression in the large 
Purkinje cells of the cerebellar cortex. At the electron microscopic level, we observed 
protein expression in stem dendrites of neurons, and also in astrocyte cells from the 
somatosensory cortex. Furthermore, the localisation of both endogenous and 
recombinant LOC689986 protein was confined to the nucleus and cytosol. Finally, 
analysis of potential interaction partners indicated a role for this protein in control of 
gene expression, and also suggested a role in the translational machinery. Our results 
could indicate a specialised role for LOC689986 in the processing of somatosensory 
information, and the protein might be involved in normal cerebellar function. Further 
functional analysis is needed to determine the biological function of LOC689986 in 
the brain and during CNS development. 
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5. General discussion 
Morphological, functional and volumetric studies of the neocortex have clearly linked 
this important brain structure to intellectual functions, as well as to psychiatric 
disorders in which cognitive decline is a prominent symptom. Based on the 
importance of the neocortex in both health and disease, we have analysed different 
cortical regions in order to identify potential regionally enriched gene expression, and 
used such genes as candidates to mine data from large genome-wide association 
studies on cognition and psychiatric disorders. 
5.1 Differentially expressed genes in the neocortex 
5.1.1 Regionally enriched cortical genes in the rat brain 
The global gene expression has been demonstrated to be highly similar across 
different areas of the adult mammalian neocortex (Paper I and [42,44,45]). However, 
specific functions are attributed to distinct cortical areas, suggesting the existence of 
patterned gene expression in order to support the functional divergence. In paper I, 
we identified 65 genes that displayed regionally enriched expression in the adult rat 
frontomedial-, temporal- or occipital cortices (30, 22 and 11 genes, respectively). 
These genes were identified by using two independent microarray platforms, in 
addition to manual re-inspection of gene expression profiles, and verification of the 
gene expression by real-time PCR (RT-PCR) analysis on a sub-set of the genes. The 
RT-PCR analyses were performed by using sequence specific probes (i.e. TaqMan® 
probes) which provide significantly less background and reduces the risk of detecting 
false positives, as compared to other and less expensive reporter molecules, such as 
DNA binding dyes (e.g. SYBR®Green). In agreement with our findings, some of the 
65 genes had previously been shown to display a patterned expression in both 
developing and adult neocortex (e.g., Latexin, RAR-related orphan receptor B, 
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Nuclear receptor subfamily 2 group F member 1, LIM domain only 4, Odd Oz/ten-m 
homolog 3 (Drosophila)) [114-118]. It is important to note that the genes were found 
to display an enriched expression in the given cortical area. This notion should not be 
mistaken for an exclusive expression, since most of the genes were also found to be 
expressed in other areas of the brain, outside of the neocortex (i.e. samples from the 
cerebellum, hippocampus or striatum). In addition, some of the genes that were 
enriched in a certain region of the neocortex also displayed expression in the other 
examined neocortical areas, though to a lesser extent. This was observed for some of 
the genes enriched in the frontomedial- and occipital cortex. The co-expression of 
genes in these two regions could possibly reflect a graded expression in the anterior-
posterior (or posterior-anterior) direction, rather than an exclusive region specific 
expression. In contrast, the strongest region specific gene expression was observed 
for the temporal cortex enriched genes. However, it is possible that the enrichment of 
genes in this region reflects a graded expression in the lateral part of the neocortex, 
rather than being restricted to the temporal cortex. Since neither regions from the 
medial, nor more regions from the lateral part of the neocortex were examined, the 
existence of such graded expression of the genes has to be explored in future studies.  
5.1.2 Functional roles of regionally enriched cortex genes  
The regionally enriched cortical genes identified from rat, and their human orthologs, 
were functionally annotated using the Panther classification system (Paper I and II, 
respectively). As expected, the regionally enriched genes displayed similar over-
representations of both biological processes and molecular functions in rat and 
human, including signal transduction, developmental processes and receptor activity. 
In support of our findings, genes involved in signal transduction have previously 
been reported to account for the main group of genes differing between various 
cortical regions in the adult human and primate brain [44]. In addition, strikingly 
many of the enriched genes had already been annotated, which could reflect their 
overall biological importance (Paper I and II). The significant over-representation of 
the genes in certain biological and molecular processes suggests that the regionally 
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enriched genes could be important in order to sustain and maintain specialised 
functions within the neocortex. By re-analysis of a data set, examining the differential 
gene expression in neurons, astrocytes and oligodendrocytes [119], we observed that 
a substantial portion of the regionally enriched genes were expressed in neurons. 
Furthermore, by searches in the Allen Mouse Brain Atlas [46], we observed that 
approximately two thirds of the genes displayed a laminar pattern of expression (e.g. 
FXYD domain-containing ion transport regulator 6 and LIM domain only 4) (Paper 
I). Interestingly, genes displaying a layer-specific pattern of expression were recently 
demonstrated to be more likely to encode proteins involved in processes such as 
synaptic transmission or ion transport. Genes displaying an evenly distributed 
expression pattern across cortical layers, on the other hand, were more likely to 
encode cellular “housekeeping” proteins [120]. The cell and/or layer specific gene 
expression for a majority of the regionally enriched genes could therefore further 
suggest functional specificity conferred by certain neuronal subtypes or layers in a 
given neocortical region.  
5.1.3 Neocortical organisation: rat versus human 
The neocortices of various mammalian species differ substantially with regard to 
surface area, connectivity and cortical fields. Although some similarities in the broad 
neocortical organisation and gene expression patterns are observed between 
mammalian species, there are cortical areas that are not well conserved in all 
mammals. The substantial surface area expansion of the human neocortex, compared 
to non-human primates and rodents, is thought to account for the additional 
functional domains found in humans [reviewed in 40]. The enlarged human 
prefrontal cortex is especially important for the cognitive abilities which set us apart 
from non-human primates and other mammalian species [reviewed in 40]. In 
addition, no homologous regions for the areas of the human brain involved in 
language processing and production (i.e. Broca’s and Wernicke’s area) have been 
observed in other mammalian species. However, some conserved features of 
neocortical organisation are observed in major groups of mammals, including areas 
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within the OCx (i.e. primary and secondary visual areas), somatosensory cortex and 
TCx (primary auditory area) [reviewed in 121,122]. Genetic factors, that specify 
regional identity, are thought to cause the broad similarities in cortical field 
organisation [reviewed in 122]. In fact, it was recently demonstrated that the 
genetically influenced neocortical regionalisation in the human brain shares 
similarities with the regionalisation in rodents [123]. Also, a comparison of the gene 
expression in the adult mouse anterior cortex, striatum and cerebellum, and the 
anatomically and functionally homologous human brain regions, revealed a very 
similar pattern of expression [52]. We were not able to determine any differential 
expression of the human orthologs to the regionally enriched rat genes in selected and 
corresponding areas of the human neocortex by RT-PCR (Paper I). However, gene 
expression searches in the Allen Brain atlas clearly demonstrated that at least a sub-
set of the genes was expressed in corresponding neocortical areas (i.e. frontal-, 
temporal- or occipital lobes) in the human brain (Paper II). 
Given the obvious medical, ethical and practical limitations in using samples from the 
human brain to study different aspects of neurobiology, rodents have become a well 
established model system. We demonstrated that the inter-individual variation in 
cortical gene expression is very low in rodents (Paper I and [42]). In contrast, the 
global gene expression in different cortical regions has been shown to vary more 
between human individuals, than among such regions within one individual [44]. 
Furthermore, the inter-individual variation is apparently larger among humans than 
chimpanzees [44]. Based on these observations, rats could therefore serve as a useful 
animal model for the identification of regionally enriched genes in the adult 
neocortex. 
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5.2 The identification of genetic factors underlying complex 
traits  
5.2.1 The search for susceptibility genes in serious psychiatric disorders 
Although both schizophrenia and bipolar affective disorder are known to be highly 
heritable mental illnesses [94-98], our understanding of the underlying genetic 
susceptibility factors remains poor. Genome-wide association studies are currently 
the most common method to examine large numbers of single nucleotide 
polymorphisms in thousands of affected individuals in comparison to matched 
healthy controls. The underlying assumption for GWASs is the “common disease-
common variant” hypothesis. According to this theory, common diseases can be 
explained by allelic variants that are present in more than 1-5% of the population 
[reviewed in 124]. Several hundreds, or even thousands of genes, each of a very small 
effect size, are thought to be involved in the susceptibility of complex common 
disorders. Only a decade ago it was generally believed that the GWAS approach 
would resolve the genetic background of complex diseases, such as schizophrenia 
and bipolar affective disorder. However, so far, no more than a handful of genes 
(genetic loci) has been linked to these serious psychiatric disorders, accounting for 
approximately 23% of the observed heritability [125]. With an estimated heritability 
of up to 70%, much of the underlying genetic architecture of schizophrenia and 
bipolar affective disorder remains “missing” or “hidden”. This could at least in part 
be explained by rare genetic variants of larger effect size, which would be difficult to 
detect by current GWAS genotyping [reviewed in 126]. Such rare variants include 
CNVs (i.e. micro-duplications or micro-deletions), which have been found to increase 
susceptibility to SCZ [106,109,110].  
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5.2.2 Convergent functional genomics approach in psychiatric genetics  
In this work we have used a functional genomics approach in order to search for 
genetic association between a set of candidate genes and certain complex traits. The 
term “convergent functional genomics” refers to the integration of multiple lines of 
evidence, in order to prioritise and integrate candidate genes for complex disorders 
[127]. In paper I, we examined areas in the adult rat neocortex, which corresponded 
to regions in the human neocortex that had previously been linked to cognitive 
functioning and psychiatric disorders. In paper II, we integrated these gene 
expression data from the animal model, and mined the differentially expressed genes 
in GWASs from a large sample of healthy adult individuals characterised by nine 
psychometric tests of cognitive functioning (i.e. test measures of intellectual 
functioning, memory, executive attention and attention). Analysis of these 
biologically relevant candidate genes, at the single gene level, demonstrated 
significant association between several of them and the test measures of cognitive 
abilities (Paper II). The temporal cortex enriched gene RORB showed the overall 
strongest association in the analysis, namely to a test measure of verbal intelligence. 
RORB has been shown to be involved in circadian rhythms and has also been 
suggested to play a role in processing of sensory information [128]. Although this 
gene had not previously been linked to cognitive functioning, it is worth noting that 
the gene was recently ranked as a top candidate for susceptibility to bipolar affective 
disorder [129,130], in which disturbance of the circadian clock has been reported 
[reviewed in 131]. We also observed marked association to the test measure of verbal 
intelligence for the Huntingtin-associated protein 1 gene, in addition to nominal 
association to the estimated full-scale intelligence. Even though no association 
between this gene and cognitive functioning had previously been reported, it is 
noteworthy that dysfunction of this gene had been linked to the neuropathology in 
Huntington disease, a disease which is often characterised by marked cognitive 
decline and psychiatric symptoms [reviewed in 132]. Three of the candidate genes 
(i.e. Complement component 1 q subcomponent-like 3, Hypocretin (orexin) receptor 1 
(HCRTR1) and Calcium binding protein 1) displayed association to all test measures 
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of attention. A link to attentional processing had previously only been reported for 
Hcrtr1, which was shown to activate the basal forebrain cholinergic system in rats 
[reviewed in 133]. Interestingly, an association between HCRTR1 and major mood 
disorder was also recently reported [134]. Although several of the candidate genes 
showed association to cognitive functioning, none of them met the conservative 
experiment-wide threshold of significance (P = 0.00014). This threshold corrects for 
the number of traits and genes tested, which may be too conservative, given the a 
priori hypothesis conferred by these candidate genes. 
As an alternative approach to search for association between single genes and 
cognitive abilities, we also analysed the cortical candidate genes as gene sets, using 
gene set enrichment analysis (Paper II). GSEA is a powerful analytical method, 
originally developed for the interpretation of gene expression data [135], that has 
recently been implemented successfully in the analysis of GWAS data [136,137]. The 
gene sets are defined on the basis of prior biological knowledge, and the GSEA 
method is used to determine whether or not the members of a gene set tend to cluster 
towards the top (or bottom) of a pre-ranked list of all the genes. We found that the 
genes differentially expressed in the temporal cortex, as a set, showed significant 
enrichment of association signal in a test measure of non-verbal intelligence. 
According to the parieto-frontal integration theory, differences in cognitive 
performance, including a test measure of non-verbal intelligence, have been 
suggested to involve a network of areas in the dorsolateral prefrontal-, parietal-, 
anterior cingulate-, temporal- and occipital cortices [66]. It is possible that the 
temporal cortex genes play a role in this network, but the functional importance of the 
genes in cognitive abilities remains to be explored. We also found that the set of 
genes showing differential expression in the occipital cortex, displayed enrichment of 
association signal to one of the test measures of attention.  
Cognitive abilities are often affected in patients suffering from schizophrenia and 
bipolar affective disorder, and can be regarded as an endophenotype for these 
psychiatric illnesses [138]. The concept of endophenotypes (also known as 
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intermediate biological phenotypes) was introduced 40 years ago, and describes an 
internal phenotype or trait that is associated with the expression of the illness 
[139,140]. The study of endophenotypes has recently gained a lot of attention in the 
search for genetic susceptibility factors in psychiatric disorders. In paper II we 
therefore also analysed the differentially expressed cortical genes, as gene sets, for 
enrichment of association signal in several large GWASs of schizophrenia and 
bipolar affective disorder. We observed an enrichment of association signal for the 
OCx gene set in one of the schizophrenia GWASs. However, no association was 
observed in the other schizophrenia GWAS data sets, which makes it hard to 
conclude on the validity of this finding.  
The reliability of our findings from the GSEA, in both cognition and psychiatric 
disorders, was addressed by three different approaches, namely by analysis of the 
cortical gene sets in GWASs of six non-psychiatric phenotypes [141], by exploring a 
gene set comprised of “housekeeping” genes across all phenotypes [142] and finally, 
by analysis of randomly generated gene sets mimicking the significant gene sets. No 
significant association was observed by these three approaches, which strongly 
supports the validity of our findings. However, the observed enrichment of 
association signal for the OCx gene set could be false positive findings, since the risk 
of generating a false positive result increases for small gene sets (n < 10 genes).  
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5.3 Characterisation of the hypothetical protein LOC689986 
gene 
One of the 65 regionally enriched genes identified in paper I, the hypothetical protein 
LOC689986 gene, was demonstrated to display the overall strongest patterned gene 
expression in the analysis. This unannotated gene showed an almost exclusive 
expression in samples from the adult rat temporal cortex, with only weak expression 
being detected in the other examined CNS samples (i.e. FMCx, OCx, striatum, 
cerebellum and hippocampus), and no apparent expression in the non-CNS samples 
(i.e. liver, kidney and spleen) (Paper I and [42]). Interestingly, the control of highly 
area- and/or layer specific gene expression seems to be linked to the mechanisms 
underlying normal function of cortical regions in primates [47]. Based on the 
observed LOC689986 gene expression in a restricted neocortical region, we 
speculated that this gene could be important for the normal function in the temporal 
cortex and related areas of the rodent brain.  
In paper III we reported that LOC689986 is highly conserved in vertebrate species, 
and that no orthologous gene is present in yeast or in invertebrates. This observation 
renders it likely that the gene is specific for the vertebrate lineage. Moreover, the high 
degree of sequence conservation, and the observation that the gene was located in a 
large syntenic block suggests an important role for this gene in supporting functional 
specialisation in vertebrates. In general, the structure and function of the vertebrate 
CNS is by far more complex than the invertebrate nervous system. It is possible that 
the gene could be involved in vertebrate specific functions related to the increased 
complexity of the nervous system. 
Detailed analysis of the LOC689986 gene expression in the adult rat parietal-, 
temporal- and occipital cortex, revealed a restricted and specific pattern of expression 
in the parieto-temporal cortex, with the overall strongest expression in the primary 
somatosensory area (Paper III). In addition, high levels of expression were also 
observed in the secondary somatosensory cortex. By in situ RNA hybridisation, we 
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confirmed the region specific expression, and revealed that the gene expression 
seemed to be confined to cortical layer IV in rats. Moreover, the distribution of the 
mouse ortholog (1700028K03Rik) of the LOC689986 protein was analysed by 
immunohistochemistry at three different postnatal stages. The mouse ortholog was 
detected in the somatosensory cortex, with a rather abrupt border towards the 
neighbouring motor cortex (at postnatal stage 5), clearly demonstrating the regional 
specificity of the protein expression. The somatosensory cortex in rodents is 
characterised by distinct barrel fields, which are located in cortical layer IV. This area 
receives tactile sensory information originating from the whiskers, and each of the 
whiskers corresponds topographically to a distinct area of the barrel cortex [143]. In a 
recent global gene expression profiling of the primary somatosensory cortex in rat, 
LOC689986 was found to be one of several genes that were up-regulated in response 
to an enriched environment [144]. Interestingly, functional characterisation of these 
up-regulated genes linked them to various functional categories, including synaptic 
plasticity, gene expression and regulation of metabolic processes [144]. The up-
regulation of LOC689986 in response to experience-dependent plasticity indicated 
that LOC689986 could be important in the regulation of somatosensory information 
[144]. In addition to the strong LOC689986 gene expression in the somatosensory 
cortex, we also observed expression in cortical regions corresponding to the primary 
and secondary auditory cortex by the detailed RT-PCR based gene expression 
analysis. These cortical areas receive and process auditory signal, and the observed 
gene expression in areas of the temporal cortex corresponded well with the original 
data from the microarray analysis.  
Based on transcriptome data from 32 different human tissues, we observed an almost 
exclusive expression of the human orthologous gene (C1orf146) in samples from 
testis. No apparent expression was detected in samples from the fetal and adult 
human brain. However, these samples were comprised of whole brain, and given that 
the human orthologous gene is expressed in similar restricted pattern as observed in 
rat, it is possible that the number of transcripts was too low to be detected. Indeed, we 
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observed an enriched expression of the human gene in samples from the human 
frontal pole in a second gene expression analysis.   
While gene expression analyses via mRNA detection is an important method for the 
examination of regional and spatial expression of a gene, the pattern and expression 
level of mRNA and protein may differ. In order to characterise the predicted protein 
encoded by the LOC689986 gene, it was therefore also important to analyse the 
distribution of protein expression. We used a custom made peptide-antibody that 
recognised an epitope in the C-terminal end of the protein (Paper III). Immunoblot 
analysis of transiently transfected cells over-expressing the recombinant protein 
confirmed the specificity of the antibody. In addition, we detected a robust protein 
band in samples from the temporal cortex by immunoblot analysis of various tissue 
lysates from the adult rat, using the custom made peptide-antibody. In contrast, only 
weak expression was detected in samples from the frontomedial- and occipital 
cortices. This finding suggested a similar patterned protein expression, as was 
observed at the gene expression level, and further indicated a specific binding of the 
peptide-antibody. However, the detected protein band from the immunoblot analysis 
of tissue lysates was approximately 4kDa larger than the predicted size of 
LOC689986. It is possible that the observed difference in size is due to post-
translational modifications, or it could reflect a different endogenous splice variant. 
Surprisingly, we also detected a protein band in tissue samples from the cingulate 
cortex, hippocampus and cerebellum. Although these data did not correspond well 
with the observed gene expression, it is possible that the gene is in fact expressed in 
these areas, however, at a level that was too low for our detection limit. Indeed, by 
immunocytochemistry analysis we found that LOC689986 was present in the 
Purkinje cells of the cerebellar cortex in mice. In the initial microarray analysis, we 
observed very low LOC689986 gene expression in whole cerebellar tissue samples 
from rats. Given that the protein is expressed in a similar cell type specific pattern in 
the rat cerebellum, it is possible that the low level of detected gene expression reflects 
the heterogeneous population of cell types analysed. The transcript would in that case 
be rather diluted, which could explain the failure in detecting higher levels of gene 
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expression in the initial analysis. The Purkinje cells are among the largest neurons in 
the brain, and are linked to motor function, learning and cognitive abilities. In the 
human brain, a reduction of these cells accompanied by morphological changes in the 
axons, has been implicated in the neurological disorder essential tremor [reviewed in 
145]. The expression of LOC689986 in the Purkinje cells is intriguing, and further 
investigation will be required to gain insight into the functional role of the protein 
within these cells. 
At the sub-cellular level, the LOC689986 protein was found to localise to both the 
nucleus and cytosol. Moreover, the endogenous LOC689986 protein clearly localised 
to dendrites, which could suggest a role for this protein in signalling pathways 
activated in response to an electrical or chemical synapse.  
In order to gain insight into potential functional roles of LOC689986, we also 
performed yeast-2-hybrid (Y2H) screens in adult and embryonic mouse brain 
libraries. Among the, in total, seven identified interaction partners of LOC689986, 
two components of the Mi-2/NuRD complex (Chd3 and Chd4) [146-149] were 
detected. This complex has been shown to bind acetylated histone tails, which 
induces transcriptional repression by remodelling of the chromatin structure. 
Interestingly, the complex displays subunit heterogeneity, varying with cell type and 
physiologic signals within a tissue. The functional specialisation of the Mi-2/NuRD 
complex has been suggested to be influenced by the subunit composition [reviewed 
in 150]. Given that the interaction between LOC689986 and components of the Mi-
2/NuRD complex can be verified, it is possible that LOC689986 could be a so far 
unknown subunit, leading to functional specialisation in distinct areas of the brain 
(e.g. somatosensory cortex). The mechanisms linking LOC689986 to experience 
dependent plasticity in rodents [144], might involve chromatin remodelling and 
transcriptional regulation in response to sensory information.  
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6. Conclusions 
The following conclusions can be drawn from this work: 
 
 A unique set of genes display differential gene expression in the rat 
frontomedial-, temporal- and occipital cortices (Paper I). 
 
 Several of the regionally enriched cortical genes displayed association to 
intellectual function (e.g. RORB associated to a test measure of verbal 
intelligence) (Paper II). 
 
 Differentially expressed genes in the temporal cortex could be involved in 
intellectual functions, as measured by a test of non-verbal intelligence in the 
healthy adult population (Paper II). 
 
 The regionally enriched neocortical genes might not be linked to disease 
susceptibility for major psychiatric disorders, at the gene set level (Paper II). 
 
 LOC689986 is a hitherto unannotated but highly conserved vertebrate-specific 
gene, displaying distinct expression patterns in the rodent brain (Paper III). 
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7. Future perspectives 
In order to further examine the potential role of the differentially expressed temporal 
cortex genes in cognitive functioning, replication studies in large independent GWAS 
samples are warranted. A requirement for this replication study will be that the 
individuals included in the GWAS are characterised by similar psychometric tests, as 
the ones used in this study. 
Further functional characterisation of LOC689986 is required to establish the 
biological relevance of this gene. First of all, by resolving the LOC689986 protein 
structure, major structural similarities (folds) might be identified, and possibly give 
hints to shared functional roles with proteins of known function. Secondly, the 
validation of identified potential protein interaction partners is of outmost 
importance, in order to determine the functional role of LOC689986. Further work 
should focus on exploring the predicted interactions in tissue lysates from parieto-
temporal cortex and cerebellum, using immunoprecipitation analysis. Should the 
interactions be verified, co-localisation analysis of LOC689986 with its potential 
interaction partners in neuronal cell cultures, could give further indications as to 
functional roles. Third, cell specific localisation of the expressed protein should be 
established. The results from the immunogold cytochemistry analysis revealed 
protein expression in neuronal dendrites and astrocyte cells. In order to explore the 
protein expression in more detail, analysis of the endogenous and recombinant 
protein expression in primary neuronal- and astrocyte cell cultures will be required. 
Finally, generation of “knock-out” or “knock-down” models would be required to 
obtain information about the possible role of the gene during development.   
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